Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
7.46M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
381K
-
Shares change
-
+61.5K
-
Total reported value, excl. options
-
$5.56M
-
Value change
-
+$893K
-
Number of buys
-
13
-
Number of sells
-
-8
-
Price
-
$14.59
Significant Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q2 2023
28 filings reported holding KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share as of Q2 2023.
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 381K shares
of 7.46M outstanding shares and own 5.11% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (129K shares), BAKER BROS. ADVISORS LP (116K shares), VANGUARD GROUP INC (27.1K shares), BlackRock Inc. (26.3K shares), Board of Trustees of The Leland Stanford Junior University (21.1K shares), GEODE CAPITAL MANAGEMENT, LLC (17.8K shares), DIMENSIONAL FUND ADVISORS LP (16.4K shares), JANE STREET GROUP, LLC (10.1K shares), BANK OF AMERICA CORP /DE/ (8.2K shares), and Knights of Columbus Asset Advisors LLC (2.42K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.